Families at risk for colorectal cancer: Risk assessment and genetic testing

Journal of Clinical Gastroenterology

Volumn 31, Issue 2, 2000, Pages 114-120

  Schoen, Robert E ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Colorectal neoplasms; Hereditary nonpolyposis; Mass screening

Indexed keywords

ADENOMATOUS POLYP; CANCER RISK; CANCER SCREENING; COLORECTAL CARCINOMA; DNA REPLICATION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HEREDITY; HUMAN; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ADENOMATOUS POLYPS; ADULT; AGE FACTORS; AGED; ALGORITHMS; BASE PAIR MISMATCH; CARRIER PROTEINS; CHILD; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENES, APC; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; IMMUNOHISTOCHEMISTRY; JEWS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; RISK; RISK ASSESSMENT;

EID: 0033857265     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200009000-00005     Document Type: Review

References (53)

1. Cancer statistics, 1999
2. A prospective study of family history and the risk of colorectal cancer
3. The accuracy of patient reports of a family history of cancer
4. Screening of patients with a positive family history of colorectal cancer
5. Incidence and familial occurrence of colorectal cancer and polyps in a health-care district of northern Italy
6. Family incidence of carcinoma of the colon and rectum in north-east Scotland
7. The Melbourne Colorectal Cancer Study. Characterization of patients with a family history of colorectal cancer
8. Colorectal cancer screening: Clinical guidelines and rationale
9. Polyp guideline: Diagnosis, treatment, and surveillance for patients with nonfamilial colorectal polyps. The Practice Parameters Committee of the American College of Gastroenterology
10. Family history of cancer and colon cancer risk: The Utah Population Database
11. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup
12. Risk of colorectal cancer in families of patients with adenomatous polyps
13. Family history of colorectal adenomatous polyps and increased risk for colorectal cancer
14. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas
15. Colorectal polyps and the risk of subsequent carcinoma
16. Treatment of small colorectal polyps: A population-based study of the risk of subsequent carcinoma
17. Lack of association between screen detection of colorectal adenoma and family history of colorectal cancer
18. Genetic counseling in hereditary nonpolyposis colorectal cancer: An extended family with MSH2 mutation
19. Genetic counseling in hereditary nonpolyposis colorectal cancer
20. Genes driving the colonoscope
21. Genetic testing in hereditary colorectal cancer: Indications and procedures
22. Familial risk and colorectal cancer
23. Colorectal cancer risk in HNPCC families: Development during lifetime and in successive generations. National Collaborative Group on HNPCC
24. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis
25. Hereditary nonpolyposis colorectal cancer: The syndrome, the genes, and historical perspectives
26. Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer
27. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer
28. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
29. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability
30. Mutation of a mutL homolog in hereditary colon cancer
31. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
32. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers
33. Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer
34. Proapoptotic gene BAX is frequently mutated in hereditary nonpolyposis colorectal cancers but not in adenomas
35. The BAX gene, the promoter of apoptosis, is mutated in genetically unstable cancers of the colorectum, stomach, and endometrium
36. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC
37. Cancer risk in mutation carriers of DNA-mismatch-repair genes
38. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes
39. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC
40. Prevalence of the 11307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer
41. Somatic instability of the APC II307K allele in colorectal neoplasia
42. Cancer, crash sites, and the new genetics of neoplasia
43. Use of SSCP analysis to identity germline mutations in HNPCC families fulfilling the Amsterdam criteria
44. DGGE screening of mutations in mismatch repair genes (hMSH2 and hMLHI) in 34 Swedish families with colorectal cancer
45. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients
46. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer
47. Mutation screening of MSH2 and MLH1 mRNA in hereditary non-polyposis colon cancer syndrome
48. Genomic DNA-based hMSH2 and hMLHI mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees
49. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease
50. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer
51. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting highlights and Bethesda guidelines
52. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium
53. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer